Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)
Status:
Recruiting
Trial end date:
2023-06-15
Target enrollment:
Participant gender:
Summary
This is a multi-center, prospective, parallel-group, open-label, randomized clinical study in
one hundred and twenty-six (126) neonates and infants diagnosed with CH.
Subjects will be randomized in a 2:1 ratio to Treatment (Tirosint®-SOL) or Control
(conventional therapy with levothyroxine sodium crushed tablets).